Synthetic polypeptides are biocompatible and biodegradable macromolecules whose
composition and architecture can vary over a wide range. Their unique ability to form …

Endothelial cells (ECs) are pivotal in maintaining vascular health, regulating hemodynamics,
and modulating inflammatory responses. Nanocarriers hold transformative potential for …

The development of new therapies is hampered by the lack of predictive, and patient-
relevant in vitro models. Organ-on-chip (OOC) technologies can potentially recreate …

The blood-brain interface poses formidable obstacles in addressing neurological conditions
such as Alzheimer's, Multiple Sclerosis, brain cancers, and cerebrovascular accidents …

The hydrogelation of amphiphilic triblock copolymers based on the poly (ethylene
glycol)(PEG) and the sheet-like polypeptides was studied in this report. The triblock …

Backgrounds: Several acute and preventive medications were developed for the treatment
of migraine. Yet, a significant proportion of patients reports an inadequate response and a …

Alzheimer's disease (AD) is the most common neurodegenerative disease among the
elderly, and the morbidity increases with the aging population aggravation. The clinical …

Blood–brain barrier (BBB) models derived from human stem cells are powerful tools to
improve our understanding of cerebrovascular diseases and to facilitate drug development …

Nanogels are emerging as promising nanocarriers for delivering therapeutic agents to treat
central nervous system (CNS) disorders. Traditional therapeutic approaches for CNS …

Commonly used sample introduction systems for inductively coupled plasma mass
spectrometry (ICP-MS) are generally not well-suited for single particle ICP-MS (spICP-MS) …